Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Icatibant

    Client Email Product

    Icatibant

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    RELATED EXCIPIENT COMPANIES

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    25
    US DMFs Filed

    US DMFs Filed

    14
    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    1
    Other Certificates

    Other Certificates

    2
    Other Suppliers

    Other Suppliers

    18
    API REF. PRICE (USD / KG)
    592,326

    API Market Place

    2
    INTERMEDIATES
    1
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    10
    Europe

    Europe

    4
    Canada

    Canada

    1
    Australia

    Australia

    3
    South Africa

    South Africa

    1
    Uploaded Dossiers

    Uploaded Dossiers

    3
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    984.00

    Annual Reports

    663.00

    FDF Market Place

    0

    EXCIPIENTS
    2
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    0

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    3

    News

    22
    REF STANDARD

    EDQM

    0

    USP

    0

    JP

    0

    Other Listed Suppliers

    0

    SERVICES

    0

    Full View ScreenFull Screen View
    Aurobindo Pharma gets U.S. FDA nod for generic Icatibant injection
    Aurobindo Pharma gets U.S. FDA nod for generic Icatibant injection

    https://www.thehindu.com/business/aurobindo-pharma-gets-us-fda-nod-for-generic-icatibant-injection/article67202351.ece

    THE HINDU
    16 Aug 2023
    Share Share
    Eugia Pharma's Generic Icatibant Acetate Receives Approval in the U.S.
    Eugia Pharma's Generic Icatibant Acetate Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213521

    FDA
    14 Aug 2023
    Share Share
    Cycle Pharmaceuticals launches SAJAZIRTM Injection, in Hereditary Angioedema
    Cycle Pharmaceuticals launches SAJAZIRTM Injection, in Hereditary Angioedema

    https://www.businesswire.com/news/home/20210928005566/en

    BUSINESSWIRE
    28 Sep 2021
    Share Share
    Glenmark Pharma`s Generic Icatibant Acetate Receives Approval In US
    Glenmark Pharma`s Generic Icatibant Acetate Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213222

    FDA
    30 May 2021
    Share Share
    Glenmark Pharma's Generic Icatibant Acetate Receives Approval In US
    Glenmark Pharma's Generic Icatibant Acetate Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213222

    FDA
    26 May 2021
    Share Share
    Sandoz launches generic Icatibant in US for rare disease hereditary angioedema
    Sandoz launches generic Icatibant in US for rare disease hereditary angioedema

    https://www.prnewswire.com/news-releases/sandoz-launches-generic-icatibant-in-us-for-rare-disease-hereditary-angioedema-strategically-enhancing-injectables-portfolio-301213222.html

    PRNEWSWIRE
    28 Jan 2021
    Share Share
    Nang Kuang`s Generic Icatibant Acetate Receives Tentative Approval In US
    Nang Kuang`s Generic Icatibant Acetate Receives Tentative Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212081

    FDA
    22 Dec 2020
    Share Share
    Fresenius Kabi Launches Icatibant Injection to Treat Acute Attacks
    Fresenius Kabi Launches Icatibant Injection to Treat Acute Attacks

    https://www.businesswire.com/news/home/20201201005198/en/Fresenius-Kabi-Launches-Icatibant-Injection-to-Treat-Acute-Attacks-of-Hereditary-Angioedema-in-Adults

    BUSINESSWIRE
    01 Dec 2020
    Share Share
    Dr Reddys's Generic Icatibant Acetate Receives Approval In US
    Dr Reddys's Generic Icatibant Acetate Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213054

    FDA
    08 Oct 2020
    Share Share
    Slayback Pharma's Generic ICATIBANT ACETATE Receives Approval In The US
    Slayback Pharma's Generic ICATIBANT ACETATE Receives Approval In The US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211501

    FDA
    13 Sep 2020
    Share Share
    Slayback Pharma announces approval of Icatibant Injection, generic - Firazyr®.
    Slayback Pharma announces approval of Icatibant Injection, generic - Firazyr®.

    https://www.prnewswire.com/news-releases/slayback-pharma-announces-approval-of-icatibant-injection-30-mg3-ml-10-mg-ml-generic-equivalent-of-firazyr-301123357.html

    PRNNEWSWIRE
    02 Sep 2020
    Share Share
    AbbVie, Amgen and Takeda repurpose drugs in joint COVID-19 study
    AbbVie, Amgen and Takeda repurpose drugs in joint COVID-19 study

    https://www.fiercepharma.com/pharma/abbvie-amgen-and-takeda-test-anti-inflammatory-drugs-joint-covid-19-study

    Angus Liu FIERCE PHARMA
    04 Aug 2020
    Share Share
    Cipla`s Generic Icatibant Acetate Receive Approval in US
    Cipla`s Generic Icatibant Acetate Receive Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212446

    FDA
    17 Jul 2020
    Share Share
    Cipla receives US FDA approval for generic Firazyr
    Cipla receives US FDA approval for generic Firazyr

    http://www.pharmabiz.com/NewsDetails.aspx?aid=129594&sid=2

    PHARMABIZ
    13 Jul 2020
    Share Share
    Fresenius Kabi`s Generic Icatibant Acetate Receives Approval in US
    Fresenius Kabi`s Generic Icatibant Acetate Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208317

    FDA
    24 Jun 2020
    Share Share
    Pharvaris debuts with $66M to push oral HAE drug through the clinic
    Pharvaris debuts with $66M to push oral HAE drug through the clinic

    https://www.fiercebiotech.com/biotech/pharvaris-debuts-66m-to-push-oral-hae-drug-through-clinic

    Amirah Al Idrus FIERCE BIOTECH
    10 Sep 2019
    Share Share
    Teva Pharms USA Generic Icatibant Acetate Receives Approval in US
    Teva Pharms USA Generic Icatibant Acetate Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210118

    FDA
    18 Jul 2019
    Share Share
    Copycats wanted: Pfizer, AZ and more under threat as China solicits generics
    Copycats wanted: Pfizer, AZ and more under threat as China solicits generics

    https://www.fiercepharma.com/pharma-asia/foreign-drugmakers-under-threat-as-china-rolls-out-drug-list-to-boost-generic

    Angus Liu FIERCE PHARMA
    21 Jun 2019
    Share Share
    The 20 most expensive retail drugs in 2018
    The 20 most expensive retail drugs in 2018

    https://www.fiercepharma.com/pharma/top-20-most-expensive-drugs-2018-featuring-names-big-and-small

    Eric Sagonowsky FIERCE PHARMA
    29 Dec 2018
    Share Share
    Cinryze (Human C1 esterase inhibotor) : Shire ViroPharma vs. CSL Behring
    Cinryze (Human C1 esterase inhibotor) : Shire ViroPharma vs. CSL Behring

    https://insight.rpxcorp.com/litigation_documents/13078576

    PATENT LITIGATION
    02 Oct 2018
    Share Share
    Sticker Shock: The Real Cost Of America's 10 Most Expensive Drugs
    Sticker Shock: The Real Cost Of America's 10 Most Expensive Drugs

    https://www.forbes.com/sites/nicolefisher/2018/06/26/sticker-shock-the-real-cost-of-americas-10-most-expensive-drugs/?ss=pharma-healthcare#1781663714d1

    Nicole Fisher FORBES
    26 Jun 2018
    Share Share
    Shire’s HAE drug Firazyr cleared for children
    Shire’s HAE drug Firazyr cleared for children

    http://www.pharmatimes.com/news/shires_hae_drug_firazyr_cleared_for_children_1209784

    Selina McKee PHARMA TIMES
    27 Oct 2017
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Chemwerth Icatibant Acetate

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search